Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 114-120

  Hjortshøj, Søren ^a   Dethlefsen, Claus ^a   Kristensen, Søren Risom ^a   Ravkilde, Jan ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute coronary syndrome; Cardiac markers; Ischaemia modified albumin; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ALBUMIN; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; MYOGLOBIN; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ADULT; AGED; ALBUMINS; ANGINA PECTORIS; ANGIOPLASTY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; TIME FACTORS;

ANGINA; NUCLEOPOLYHEDROVIRUS;

EID: 64849094263     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.01.033     Document Type: Article

References (34)

1. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
2. Ravkilde J. Risk stratification in acute coronary syndrome using cardiac troponin I. Clin Chem 46 (2000) 443-444
3. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., and Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356 (2000) 9-16
4. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-e375
5. Bar-Or D., Lau E., Rao N., Bampos N., Winkler J.V., and Curtis C.G. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia. Ann Emerg Med 34 4 Suppl (1999) S56 (Abstract)
6. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19 (2000) 311-315
7. Abadie J.M., Blassingame C.L., and Bankson D.D. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 35 (2005) 66-72
8. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470
9. Collinson P.O., Gaze D.C., Bainbridge K., et al. Utility of admission cardiac troponin and Ischemia Modified Albumin measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 23 (2006) 256-261
10. Roy D., Quiles J., Aldama G., et al. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97 (2004) 297-301
11. Sinha M.K., Roy D., Gaze D.C., Collinson P.O., and Kaski J.C. Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 (2004) 29-34
12. Wu A.H., Morris D.L., Fletcher D.R., Apple F.S., Christenson R.H., and Painter P.C. Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 1 (2001) 147-151
13. Peacock F., Morris D.L., Anwaruddin S., et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152 (2006) 253-262
14. Bar-Or D., Winkler J.V., Vanbenthuysen K., Harris L., Lau E., and Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
15. Bar-Or D., Rael L.T., Bar-Or R., et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387 (2008) 120-127
16. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Medicine 2008; In press.
17. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
18. Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 50 (2004) 327-332
19. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., and Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 49 (2003) 1331-1336
20. Pelsers M.M., Chapelle J.P., Knapen M., et al. Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 45 (1999) 441-443
21. Silber S., Albertsson P., Aviles F.F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
22. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
23. Fraser G.G., and Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27 (1989) 409-437
24. Norgaard B.L., Andersen K., Thygesen K., et al. Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart 90 (2004) 739-744
25. Jernberg T., Lindahl B., and Wallentin L. ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol 34 (1999) 1413-1419
26. Hjortshoj S., Dethlefsen C., Kristensen S.R., and Ravkilde J. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers. Scand J Clin Lab Invest (2007) 1-5
27. Ilva T., Lund J., Porela P., et al. Early markers of myocardial injury: cTnI is enough. Clinica Chimica Acta 400 (2009) 82-85
28. Apple F.S., Quist H.E., Otto A.P., Mathews W.E., and Murakami M.M. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 48 (2002) 1097-1100
29. Can M., Demirtas S., Polat O., and Yildiz A. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 23 (2006) 537-539
30. Falkensammer J., Stojakovic T., Huber K., et al. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin Chem Lab Med 45 (2007) 535-540
31. Roy D., Quiles J., Sharma R., et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 50 (2004) 1656-1660
32. Troxler M., Thompson D., and Homer-Vanniasinkam S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 31 (2006) 164-169
33. Andersen H.R., Nielsen T.T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
34. Apple F.S., Jesse R.L., Newby L.K., Wu A.H., and Christenson R.H. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 115 (2007) e352-e355